Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Serum anticholinergic activity and motor performance in elderly persons.

Nebes RD, Pollock BG, Halligan EM, Kirshner MA, Houck PR.

J Gerontol A Biol Sci Med Sci. 2007 Jan;62(1):83-5.

PMID:
17301043
2.

The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.

Nebes RD, Pollock BG, Perera S, Halligan EM, Saxton JA.

Am J Geriatr Pharmacother. 2012 Jun;10(3):185-92. doi: 10.1016/j.amjopharm.2012.03.003. Epub 2012 Apr 24.

3.

Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.

Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M.

Arch Gen Psychiatry. 2003 Feb;60(2):198-203.

PMID:
12578438
4.

Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.

Nebes RD, Pollock BG, Halligan EM, Houck P, Saxton JA.

Am J Geriatr Psychiatry. 2011 Feb;19(2):169-75. doi: 10.1097/JGP.0b013e3181e4490d.

5.

Use of Medications with Anticholinergic Activity and Self-Reported Injurious Falls in Older Community-Dwelling Adults.

Richardson K, Bennett K, Maidment ID, Fox C, Smithard D, Kenny RA.

J Am Geriatr Soc. 2015 Aug;63(8):1561-9. doi: 10.1111/jgs.13543. Epub 2015 Jul 22.

PMID:
26200894
6.

Anticholinergic burden is associated with recurrent and injurious falls in older individuals.

Zia A, Kamaruzzaman S, Myint PK, Tan MP.

Maturitas. 2016 Feb;84:32-7. doi: 10.1016/j.maturitas.2015.10.009. Epub 2015 Oct 23.

PMID:
26531071
7.

Serum anticholinergic activity levels and delirium in the elderly.

Tune LE.

Semin Clin Neuropsychiatry. 2000 Apr;5(2):149-53. Review.

PMID:
10837103
8.

Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.

Lampela P, Lavikainen P, Garcia-Horsman JA, Bell JS, Huupponen R, Hartikainen S.

Drugs Aging. 2013 May;30(5):321-30. doi: 10.1007/s40266-013-0063-2.

PMID:
23475596
9.

[Anticholinergic drugs and CNS relevance for therapy].

Madersbacher H.

Krankenpfl J. 2005;43(7-10):187-8. German. No abstract available.

PMID:
16515260
10.

Serum anticholinergic activity, white matter hyperintensities, and cognitive performance.

Nebes RD, Pollock BG, Meltzer CC, Saxton JA, Houck PR, Halligan EM, DeKosky ST.

Neurology. 2005 Nov 8;65(9):1487-9.

PMID:
16275844
11.

Anticholinergic drugs and physical function among frail elderly population.

Landi F, Russo A, Liperoti R, Cesari M, Barillaro C, Pahor M, Bernabei R, Onder G.

Clin Pharmacol Ther. 2007 Feb;81(2):235-41. Epub 2006 Dec 27.

PMID:
17192773
12.

Anticholinergic drug burden in older people's brain - how well is it measured?

Kersten H, Wyller TB.

Basic Clin Pharmacol Toxicol. 2014 Feb;114(2):151-9. doi: 10.1111/bcpt.12140. Epub 2013 Oct 19. Review.

13.

Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.

Konishi K, Hori K, Uchida H, Watanabe K, Tominaga I, Kimura M, Hosoyamada M, Shibasaki T, Kataoka A, Hachisu M.

Psychogeriatrics. 2010 Mar;10(1):34-8. doi: 10.1111/j.1479-8301.2010.00310.x.

14.

Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.

Oefelein MG.

Drug Saf. 2011 Sep 1;34(9):733-54. doi: 10.2165/11592790-000000000-00000. Review.

PMID:
21830836
15.

Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.

Koshoedo S, Soiza RL, Purkayastha R, Mangoni AA.

Am J Geriatr Pharmacother. 2012 Aug;10(4):251-7. doi: 10.1016/j.amjopharm.2012.06.003. Epub 2012 Jul 13.

PMID:
22795433
16.

Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.

Ness J, Hoth A, Barnett MJ, Shorr RI, Kaboli PJ.

Am J Geriatr Pharmacother. 2006 Mar;4(1):42-51.

PMID:
16730620
17.

Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home.

Landi F, Dell'Aquila G, Collamati A, Martone AM, Zuliani G, Gasperini B, Eusebi P, Lattanzio F, Cherubini A.

J Am Med Dir Assoc. 2014;15(11):825-9. doi: 10.1016/j.jamda.2014.08.002. Epub 2014 Oct 3.

PMID:
25282629
18.

Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.

Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, Salerno F, Corrao S, Marengoni A, Iorio A, Marcucci M, Violi F, Mannucci PM.

Drugs Aging. 2013 Feb;30(2):103-12. doi: 10.1007/s40266-012-0044-x.

PMID:
23239364
19.

Use of medications with anticholinergic properties and cognitive function in a young-old community sample.

Low LF, Anstey KJ, Sachdev P.

Int J Geriatr Psychiatry. 2009 Jun;24(6):578-84. doi: 10.1002/gps.2157.

PMID:
19021151
20.

Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.

Han L, Agostini JV, Allore HG.

J Am Geriatr Soc. 2008 Dec;56(12):2203-10. doi: 10.1111/j.1532-5415.2008.02009.x.

Supplemental Content

Support Center